122 related articles for article (PubMed ID: 11768601)
21. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis.
Chen X; Guan J; Song Y; Chen P; Zheng H; Tang C; Wu Q
J Hum Genet; 2008; 53(3):227-238. PubMed ID: 18188667
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study.
Santonocito C; Paradisi A; Capizzi R; Concolino P; Lavieri MM; Lanza Silveri S; De Luca D; Catricalà C; Di Carlo A; Zuppi C; Ameglio F; Capoluongo E
Clin Chim Acta; 2008 Apr; 390(1-2):104-9. PubMed ID: 18237549
[TBL] [Abstract][Full Text] [Related]
23. IGF gene polymorphisms and breast cancer in African-American and Hispanic women.
Sarkissyan M; Mishra DK; Wu Y; Shang X; Sarkissyan S; Vadgama JV
Int J Oncol; 2011 Jun; 38(6):1663-73. PubMed ID: 21455574
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.
Figer A; Karasik YP; Baruch RG; Chetrit A; Papa MZ; Sade RB; Rizel S; Friedman E
Isr Med Assoc J; 2002 Oct; 4(10):759-62. PubMed ID: 12389335
[TBL] [Abstract][Full Text] [Related]
25. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
26. Cytosine-Adenosine (CA)n repeats polymorphism in IGF-I gene and early growth in infants born appropriate and small for gestational age.
Kytnarova J; Vesela K; Zlatohlavkova B; Dohnalova A; Fedorova M; Krsek M; Zeman J
Neuro Endocrinol Lett; 2009; 30(4):501-5. PubMed ID: 20010501
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
[TBL] [Abstract][Full Text] [Related]
28. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
29. IGF-I in epithelial ovarian cancer and its role in disease progression.
Brokaw J; Katsaros D; Wiley A; Lu L; Su D; Sochirca O; de la Longrais IA; Mayne S; Risch H; Yu H
Growth Factors; 2007 Oct; 25(5):346-54. PubMed ID: 18236213
[TBL] [Abstract][Full Text] [Related]
30. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort.
Uthra S; Raman R; Mukesh BN; Rajkumar SA; Kumari R P; Agarwal S; Paul PG; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
Ophthalmic Res; 2007; 39(5):294-9. PubMed ID: 17851271
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
32. Association between CA repeat polymorphism in IGF1 gene promoter and colorectal cancer risk in a native Chinese population.
Chao XL; Wang LL; Liu R; Li Y; Zhou XJ
Neoplasma; 2019 Nov; 66(6):1002-1008. PubMed ID: 31305125
[TBL] [Abstract][Full Text] [Related]
33. Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults.
Hand BD; Kostek MC; Ferrell RE; Delmonico MJ; Douglass LW; Roth SM; Hagberg JM; Hurley BF
J Appl Physiol (1985); 2007 Nov; 103(5):1678-87. PubMed ID: 17761791
[TBL] [Abstract][Full Text] [Related]
34. Association between the length of a CA dinucleotide repeat in the EGFR and risk of breast cancer.
Jami MS; Hemati S; Salehi Z; Tavassoli M
Cancer Invest; 2008 May; 26(4):434-7. PubMed ID: 18443966
[TBL] [Abstract][Full Text] [Related]
35. Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms.
Takeo C; Negishi E; Nakajima A; Ueno K; Tatsuno I; Saito Y; Amano K; Hirai A
Gend Med; 2005 Jun; 2(2):96-105. PubMed ID: 16115604
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor 1 gene polymorphism in women with breast cancer.
Costa-Silva DR; da Conceição Barros-Oliveira M; Borges RS; Campos-Verdes LM; da Silva-Sampaio JP; Escorcio-Dourado CS; Martins LM; Alencar AP; Baracat EC; Silva VC; da Silva BB
Med Oncol; 2017 Apr; 34(4):59. PubMed ID: 28315227
[TBL] [Abstract][Full Text] [Related]
38. The estimation of GC repeats in promoter P1 of IGF-1 gene and their influence on IGF-1 plasma levels in stable angina patients.
Burchardt P; Nowak W; Zurawski J; Gozdzicka-Jozefiak A; Siminiak T
Protein J; 2010 Oct; 29(7):524-9. PubMed ID: 20872173
[TBL] [Abstract][Full Text] [Related]
39. IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
Henningson M; Hietala M; Törngren T; Olsson H; Jernström H
Fam Cancer; 2011 Jun; 10(2):173-85. PubMed ID: 21113804
[TBL] [Abstract][Full Text] [Related]
40. Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer.
Pacholska-Bogalska J; Józefiak A; Nowak W; Kedzia W; Kwaśniewska A; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2011; 32(4):393-8. PubMed ID: 21941959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]